Histogen Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was USD 3.77 million compared to USD 1.03 million a year ago. Net loss was USD 10.62 million compared to USD 14.95 million a year ago.

Basic loss per share from continuing operations was USD 3.46 compared to USD 7.79 a year ago.